Literature Archives

Although overall diagnostic yield did not differ significantly between the groups, the 22-gauge fine needle biopsy yielded a significantly higher rate of adequate histologic tissue (98.6% versus 86.7%, P < 0.001) and larger core samples, making it a valuable tool when tissue architecture preservation is needed.

Pleural fluid IL-9 levels were significantly higher in tuberculous pleural effusion than in malignant effusion, achieving an AUC of 0.987 with 98.0% sensitivity and 92.59% specificity at a cutoff of 748.47 ng/L (P < 0.001), outperforming traditional markers like ADA and CEA and offering a promising new adjunctive diagnostic tool for IP practice.

Adopting advanced navigational platforms and tissue-acquisition tools significantly improves diagnostic yields—such as an increase from 57% with ENB to 72% with ssRAB (RR = 1.26, 95% CI 1.09–1.45, P < 0.001)—even when tackling smaller, more challenging lesions. However, clinicians must carefully weigh these gains against higher procedural radiation and pneumothorax risks.

For interventional pulmonologists, these guidelines show that routine confirmatory mediastinoscopy can be safely omitted after a negative CP-EBUS, as pooled analysis demonstrated no significant difference in missed N2 or N3 disease compared to CP-EBUS alone with an RD of 0.03 (-0.03 to 0.09, P = 0.18). Furthermore, CP-EBUS should be prioritized for peripheral tumors greater than 3 cm due to a significantly higher risk of occult N2 disease (RD 0.06, 0.04 to 0.07, P = 0.0016), while invasive staging can be bypassed for pure ground-glass nodules.

Successful pleurodesis is an independent predictor of improved overall survival, with a three-month landmark hazard ratio of 0.23 (P < 0.001). Interventional pulmonologists should prioritize timely, effective pleural procedures to achieve durable pleurodesis success and modify the disease course beyond immediate palliation.

Flexible bronchoscopy with bronchial forceps serves as an effective initial management strategy for aspirated dental objects, achieving a 75% initial retrieval success rate.

While 93% of pleural diagnoses can be established with 3 or fewer biopsies, interventional pulmonologists should tailor their sampling strategy based on pleural morphology and the need for biomarker profiling.

Minor esophageal mucosal alterations occur in 89.2 percent of EUS-B-FNA procedures, but they are benign and clinically insignificant when performed by experienced interventional pulmonologists, supporting its continued safe use in thoracic staging.

Accurate CPT coding and meticulous documentation are critical for interventional pulmonologists to ensure proper reimbursement, reflect procedural complexity, and safeguard against billing compliance audits, though specific numerical data were not evaluated in this qualitative review.

Advanced robotic-assisted bronchoscopy makes sampling multiple lung nodules in a single session safe and essential, proving that concurrent nodules do not always share the same pathology.

Highlights methodological caveats to consider when interpreting clinical trial data for bronchoscopic denervation procedures.

Patient selection for bronchoscopic targeted lung denervation in COPD requires deeper physiologic and phenotypic understanding.